Perspective Therapeutics, Inc. — Form SCHEDULE 13D/A
Filed September 23, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
Lantheus Holdings, Inc. filed an amended Schedule 13D/A regarding its beneficial ownership position in Perspective Therapeutics, Inc. (market value ~$212.9M). The filing document itself contains no substantive details—no share counts, ownership percentages, transaction amounts, or dates of changes are provided in the accessible text. This is a procedural amendment to a prior 13D filing, but the specific nature and magnitude of the amended disclosure cannot be determined from this submission.
Why this rating
Amendment filing lacks disclosed specifics (shares, %, amounts). Cannot assess materiality without content details. Procedurally routine Schedule 13D/A amendment.
See more from September 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.